Australian reproductive biotechnology company Memphasys enhances board with appointment of Michael Atkins as Non-Executive Director
By API User
Australian-based reproductive biotechnology company, Memphasys Limited (ASX: MEM), has enhanced its board with the appointment of successful corporate executive Michael Atkins as an independent non-executive director, effective immediately. Since 1987 Michael has been involved with the formation of, and capital raising for, and management of, many listed companies on the ASX, both as a Chairman/Director … Continued